Biomarker-Based Approach to α-Synucleinopathies: Lessons from Neuropathology
- PMID: 39360851
- PMCID: PMC11657033
- DOI: 10.1002/mds.30028
Biomarker-Based Approach to α-Synucleinopathies: Lessons from Neuropathology
References
-
- Simuni T, Chahine LM, Poston K, et al. A biological definition of neuronal alpha‐synuclein disease: towards an integrated staging system for research. Lancet Neurol 2024;23(2):178–190. - PubMed
-
- Hoglinger GU, Adler CH, Berg D, et al. A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria. Lancet Neurol 2024;23(2):191–204. - PubMed
-
- Lewy F, Paralysis agitans I. Pathologische Anatomie. In: Lewandowsky M, Abelsdorff G, eds. Handbuch der Neurologie. Vol. 3. Berlin: Springer Verlag; 1912:920–933.
-
- Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and shy‐Drager syndrome). J Neurol Sci 1989;94(1–3):79–100. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
